<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        306-186-21
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ADOL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PARACETAMOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        125
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Rectal use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Suppository
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        49.00
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02BE01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>adol</strong> suppositories contain a medicine called paracetamol. This belongs to a group of medicines called pain-killers (analgesics). A suppository is a small, torpedo-shaped, medicine which is inserted into the back passage (rectum).</p><p><strong>adol</strong> suppositories are used to treat pain and high temperature (fever), they are used when it is difficult to take paracetamol as tablets, suspension or syrup.</p><p>&bull; <strong>adol</strong> 125mg suppositories are for children aged from 1 to 5 years.</p><p>&bull; <strong>adol</strong> 250mg suppositories are for children aged from 6 to 12 years.</p><p>&bull; <strong>adol</strong> 500mg suppositories are for adults and children over 10 years of age.</p><p>You must talk to a doctor if you do not feel better or if you feel worse after 3 days</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use adol Suppositories:</strong></p><p>&middot;&nbsp;&nbsp; If you are allergic to paracetamol or any of the other ingredients of this medicine (listed in Section 6).</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before using <strong>adol</strong> suppositories.</p><p><strong>Take special care with the use of adol suppositories and talk to your pharmacist or doctor if: </strong></p><p>&middot;&nbsp;&nbsp; You have problems with your liver or kidneys.</p><p><strong>Other medicines and adol suppositories</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is because <strong>adol</strong> suppositories can have an effect on the way some medicines work and some medicines can have an effect on how <strong>adol</strong> suppositories work.</p><p>In particular tell your doctor or pharmacist if you are taking any of the following:</p><p>&middot;&nbsp;&nbsp; Other medicines containing paracetamol &ndash; <strong>do not use adol suppositories at the same time</strong></p><p>&middot;&nbsp;&nbsp; Medicines to treat nausea (feeling sick) and vomiting (being sick), such as metoclopramide and domperidone</p><p>&middot;&nbsp;&nbsp; Colestyramine, used to reduce the level of cholesterol (fat) in the blood</p><p>&middot;&nbsp;&nbsp; Medicines called anticoagulants, such as warfarin, used for treating blood clots or &ldquo;thinning the blood&rdquo;</p><p>&middot;&nbsp;&nbsp; Medicines called anticonvulsants used for treating epilepsy or fits (e.g. phenytoin, carbamazepine)<br />Phenytoin may reduce the effect of paracetamol on relieving pain and fever and may increase the formation of the toxic N-acetyl-p-benzoquinone imine (NAPQI) metabolite of paracetamol which may lead to increased risk of liver toxicity.</p><p>&middot;&nbsp;&nbsp; The antibiotic rifampicin.</p><p>&middot;&nbsp;&nbsp; Flucloxacillin (antibiotic), due to a serious risk of blood and fluid abnormality (high anion gap metabolic acidosis) that must have urgent treatment and which may occur particularly in case of severe renal impairment, sepsis (when bacteria and their toxins circulate in the blood leading to<br />organ damage), malnutrition, chronic alcoholism, and if the maximum daily doses of paracetamol are used.</p><p>&middot;&nbsp;&nbsp; Barbiturates (a type of sedative).</p><p>&middot;&nbsp;&nbsp; Chloramphenicol (a medicine used to treat bacterial infections).</p><p>&middot;&nbsp;&nbsp; Probenecid (a medicine used to prevent gout and, occasionally, to increase blood levels of the antibiotic penicillin)</p><p><strong>Pregnancy and breast-feeding</strong></p><p><u>If necessary</u>, <strong>adol</strong> 500mg suppositories can be used during pregnancy. You should use the lowest possible dose that reduces your pain and/or your fever and use it for the shortest time possible. Contact your doctor if the pain and/or fever are not reduced or if you need to take the medicine more often.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine is for rectal use only. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>The recommended dose is:</strong></p><p><img src="data:image/jpeg;base64,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" alt="" width="558" height="217" vspace="0" hspace="0" border="0" style="width:558px;height:217px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>Do not use more suppositories than stated above</p><p>Consult your doctor if symptoms get worse or do not improve within 3 days.</p><p><strong><u>How to use the suppositories:</u></strong></p><p>&middot;&nbsp;&nbsp; The bowels need to be empty when you use this medicine. If you need to go to the toilet, make sure that you do it before you use the suppository.</p><p>&middot;&nbsp;&nbsp; It may be easier to use the suppository if you are lying on your front or side on a bed.</p><p>&middot;&nbsp;&nbsp; Wash your hands. Then peel the wrapping apart to take out the suppository. Do not break the suppository before use.</p><p>&middot;&nbsp;&nbsp; Gently push the suppository into your back passage with the pointed end first. To make it easier to use the suppository you may warm it slightly between your hands beforehand.</p><p>&middot;&nbsp;&nbsp; Try to keep still for a minute or two and then wash your hands.</p><p>&middot;&nbsp;&nbsp; If you need to use another suppository, then follow the above procedure again.</p><p><strong>If you use more adol suppositories than you should</strong></p><p>Talk to a doctor at once if you use too much of this medicine even if you feel well. This is because too much paracetamol can cause delayed, serious liver damage.</p><p><strong>If you forget to use adol suppositories</strong></p><p>Do not use a double dose to make up for the forgotten dose.</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Stop using adol suppositories immediately and call your doctor if you notice you have any signs of allergic reaction. </strong></p><p>Signs of an allergic reaction include a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.<strong> The following side effects can happen with this medicine.</strong></p><p><strong>Common side effects </strong>(affects more than 1 in 100 people taking this medicine):</p><p>&middot;&nbsp;&nbsp; Redness or soreness in and around the back passage.</p><p><strong>Rare side effects </strong>(affects less than 1 in 1000 people taking this medicine):</p><p>&middot;&nbsp;&nbsp; Blood problems. If these happen, you may bruise or bleed more easily than usual, be more susceptible to infections, or get a high temperature (fever) and ulcers in the mouth and throat</p><p>&middot;&nbsp;&nbsp; Liver problems. Symptoms may include jaundice (yellowing of the skin or whites of the eyes).</p><p>If you gets any of the side effects mentioned above, or get any side effect not mentioned in this leaflet, talk to your doctor or pharmacist.</p><p><strong><u>Reporting of side effects</u></strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:</p><p><strong>● </strong><strong>UAE:</strong></p><p><strong>&nbsp;&nbsp; Pharmacovigilance and Medical Device Section</strong></p><p><strong>&nbsp;&nbsp; Drug Department - U.A.E M.O.H</strong></p><p><strong>&nbsp;&nbsp; Hotline: </strong>80011111</p><p><strong>&nbsp;&nbsp; Email: </strong>pv@mohap.gov.ae</p><p><strong>&nbsp;&nbsp; P.O. Box: </strong>1853 Dubai U.A.E.</p><p><strong>● Oman:</strong></p><p><strong>&nbsp;&nbsp; Department of Pharmacovigilance &amp; Drug Information</strong></p><p><strong>&nbsp;&nbsp; Directorate General of Pharmaceutical Affairs &amp; Drug Control</strong></p><p><strong>&nbsp;&nbsp; Ministry of Health, Sultanate of Oman</strong></p><p><strong>&nbsp;&nbsp; Phone Nos. </strong>0096822357687 / 0096822357686</p><p><strong>&nbsp;&nbsp; Fax: </strong>0096822358489</p><p><strong>&nbsp;&nbsp; Email: </strong>dg-padc@moh.gov.om</p><p><strong>&nbsp;&nbsp; Website</strong>: www.moh.gov.om</p><p><strong>● KSA:</strong></p><p><strong>&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC): </strong></p><p><strong>&nbsp;&nbsp; SFDA Call Center: </strong>19999</p><p><strong>&nbsp;&nbsp; E-mail: </strong>npc.drug@sfda.gov.sa<strong> </strong></p><p><strong>&nbsp;&nbsp; Website</strong>: https://ade.sfda.gov.sa</p><p><strong>● Other GCC States:</strong></p><p><strong>- </strong>Please contact the relevant competent authority</p><p>By reporting side effects you can help provide more information on the safety of this medicine<strong>.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep this medicine out of the reach and sight of children.</p><p>- Store below 30&ordm;C, in the original container, protected from heat.&nbsp;&nbsp;</p><p>- Do not use <strong>adol</strong> suppositories after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.</p><p>- Do not use <strong>adol</strong> suppositories if you notice any visible sign of deterioration.</p><p>&nbsp;&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose<br />&nbsp;&nbsp; of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is paracetamol.</p><p>Each suppository contains 125mg, 250mg or 500mg of paracetamol.</p><p>Other ingredient: Semi-synthetic glycerides of saturated fatty acids from C8 and C18 [Suppocire AM].</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                adol 125mg, 250mg & 500mg suppositories are available in packs of 10 suppositories and Hospital packs of 100 suppositories.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot;Julphar&quot;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                22/03/2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">تحتوي<strong> </strong>تحاميل<strong> أدول </strong>على<strong> </strong>المادة<strong> </strong>الدوائية<strong> </strong>باراسيتامول<strong> </strong>التي<strong> </strong>تنتمي<strong> </strong>إلى<strong> </strong>مجموعة<strong> </strong>الأدوية<strong> </strong>المعروفة<strong> </strong>بإسم<strong> </strong>مسكنات<strong> </strong>الألم<strong>.</strong></p><p dir="RTL">تعد<strong> </strong>التحميلة<strong> </strong>أحد<strong> </strong>الأشكال<strong> </strong>الدوائية<strong> </strong>والتي<strong> </strong>تتصف<strong> </strong>بأنها<strong> </strong>صغيرة<strong> </strong>الحجم<strong> </strong>ومخروطية<strong> </strong>الشكل<strong> </strong>ويتم<strong> </strong>وضعها<strong> </strong>في<strong> </strong>فتحة<strong> </strong>الشرج<strong> </strong>(المستقيم).</p><p dir="RTL">تستخدم<strong> </strong>تحاميل<strong> أدول </strong>لعلاج<strong> </strong>الألم<strong> </strong>وارتفاع<strong> </strong>درجة<strong> </strong>حرارة<strong> </strong>الجسم<strong> </strong>(الحمى)<strong> </strong>من<strong> </strong>قبل<strong> </strong>الذين<strong> </strong>يجدون<strong> </strong>صعوبة<strong> </strong>في<strong> </strong>تناول<strong> </strong>باراسيتامول<strong> </strong>على<strong> </strong>هيئة<strong> </strong>أقراص،<strong> </strong>معلق<strong> </strong>أو<strong> </strong>شراب<strong>.</strong></p><p dir="RTL">●<strong> </strong>تحاميل<strong> أدول </strong>125 ملغم للأطفال بعمر 1 &ndash; 5 سنوات<strong>.</strong></p><p dir="RTL">●<strong> </strong>تحاميل<strong> أدول </strong>250 ملغم للأطفال بعمر 6 &ndash; 12<strong> </strong>سنة<strong>.</strong></p><p dir="RTL">●<strong> </strong>تحاميل<strong> أدول </strong>500 ملغم للبالغين والأطفال بعمر 10 سنوات<strong> </strong>فما<strong> </strong>فوق<strong>.&nbsp; </strong></p><p>يجب<strong> </strong>عليك<strong> </strong>التحدث<strong> </strong>إلى<strong> </strong>طبيبك<strong> </strong>المعالج<strong> </strong>في<strong> </strong>حال<strong> </strong>عدم<strong> </strong>الشعور<strong> </strong>بالتحسن<strong> </strong>أو<strong> </strong>في<strong> </strong>حال<strong> </strong>تفاقم<strong> </strong>حالتك<strong> </strong>الصحية<strong> </strong>بعد<strong> </strong>مرور<strong> </strong>3<strong> </strong>أيام<strong> </strong>من<strong> </strong>تناول<strong> </strong>هذا<strong> </strong>الدواء<strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عليك عدم استعمال تحاميل أدول:</strong></p><p dir="RTL">●<strong> </strong>إذا<strong> </strong>كنت<strong> </strong>تعاني<strong> </strong>من<strong> </strong>الحساسية<strong> </strong>تجاه<strong> </strong>باراسيتامول<strong> </strong>أو<strong> </strong>تجاه<strong> </strong>أياً<strong> </strong>من<strong> </strong>المواد<strong> </strong>الأخرى<strong> </strong>في<strong> </strong>هذا<strong> </strong>الدواء<strong> (</strong>المذكورة<strong> </strong>في<strong> </strong>البند<strong> </strong>رقم<strong> </strong>6).</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">يرجى<strong> </strong>منك<strong> </strong>التحدث<strong> </strong>مع<strong> </strong>طبيبك<strong> </strong>المعالج<strong> </strong>أو<strong> </strong>الصيدلي<strong> </strong>الذي<strong> </strong>تتعامل<strong> </strong>معه<strong> </strong>قبل<strong> </strong>استعمال<strong> </strong>تحاميل<strong> أدول.</strong></p><p dir="RTL"><strong>يجب توخي الحذر قبل استعمال تحاميل أدول والتحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا: </strong></p><p dir="RTL">●<strong> </strong>كنت<strong> </strong>تعاني<strong> </strong>من<strong> </strong>اضطرابات<strong> </strong>في<strong> </strong>الكبد<strong> </strong>أو<strong> </strong>الكلى<strong>.</strong></p><p dir="RTL"><strong>استعمال الأدوية الأخرى بالتزامن مع تحاميل أدول</strong></p><p dir="RTL">يرجى<strong> </strong>منك<strong> </strong>إخبار<strong> </strong>طبيبك<strong> </strong>المعالج<strong> </strong>أو<strong> </strong>الصيدلي<strong> </strong>الذي<strong> </strong>تتعامل<strong> </strong>معه<strong> </strong>إذا<strong> </strong>كنت<strong> </strong>تتناول،<strong> </strong>تناولت<strong> </strong>مؤخراً<strong> </strong>أو<strong> </strong>قد<strong> </strong>تتناول<strong> </strong>أية<strong> </strong>أدوية<strong> </strong>أخرى،<strong> </strong>حيث<strong> </strong>أن<strong> </strong>تحاميل<strong> أدول </strong>قد<strong> </strong>تؤثرعلى<strong> </strong>آلية<strong> </strong>عمل<strong> </strong>بعض<strong> </strong>الأدوية<strong> </strong>الأخرى<strong> </strong>وبالمثل<strong> </strong>فإن<strong> </strong>بعض<strong> </strong>الأدوية<strong> </strong>قد<strong> </strong>تؤثر<strong> </strong>على<strong> </strong>آلية<strong> </strong>عمل<strong> </strong>تحاميل<strong> أدول.</strong></p><p dir="RTL">بصورة<strong> </strong>خاصة،<strong> </strong>يجب<strong> </strong>عليك<strong> </strong>أن<strong> </strong>تخبر<strong> </strong>طبيبك<strong> </strong>المعالج<strong>&nbsp; </strong>أو<strong> </strong>الصيدلي<strong> </strong>الذي<strong> </strong>تتعامل<strong> </strong>معه<strong> </strong>إذا<strong> </strong>كنت<strong> </strong>تتناول<strong> </strong>أحد<strong> </strong>الأدوية<strong> </strong>التالية<strong>: </strong></p><p dir="RTL">●<strong> </strong>الأدوية<strong> </strong>الأخرى<strong> </strong>التي<strong> </strong>تحتوي<strong> </strong>على<strong> </strong>باراسيتامول<strong> &ndash; يجب عدم استعمال تحاميل أدول بالتزامن مع هذه الأدوية.</strong></p><p dir="RTL">●<strong> </strong>الأدوية التي تستخدم لعلاج الغثيان (الشعور بالإعياء) والتقيؤ (التوعك)، على سبيل المثال ميتوكلوبراميد&nbsp; ودومبيريدون.</p><p dir="RTL">● كوليسترامين، يستخدم لتقليل مستوى الكوليسترول (الدهون) في الدم.</p><p dir="RTL">● مضادات التخثر على سبيل المثال الوارفارين، تستخدم لعلاج الجلطات الدموية أو (ترقيق الدم).</p><p dir="RTL">● مضادات الاختلاج، تستخدم لعلاج الصرع أو النوبات التشنجية (على سبيل المثال فينيتوين، كاربامازيبين) قد يقلل الفينيتوين من<br />&nbsp;&nbsp;&nbsp; تأثير الباراسيتامول المسكن للألم والخافض للحرارة، كما قد يزيد من تكوين مستقلب الباراسيتامول السام (إن - أسيتيل - بي-<br />&nbsp;&nbsp;&nbsp; بنزوكينون إمين) مما يؤدي إلى زيادة خطر حدوث تسمم الكبد.</p><p dir="RTL">● المضاد الحيوي الذي يعرف باسم ريفامبيسين.</p><p dir="RTL">● فلوكلوكساسیلین (مضاد حیوي)، نظرا لخطر حدوث نتائج غیر طبیعیة في الدم والسوائل (الحماض الأیضي ذو الفجوة الأنیونیة<br />&nbsp;&nbsp; المرتفعة) الذي یجب أن یخضع للعلاج العاجل والذي قد یحدث بشكل خاص في حالات القصورالكلوي الشدید، والإنتان (عندما<br />&nbsp;&nbsp; تنتشر البكتیریا وسمومھا في الدم مما یؤدي إلى تلف الأعضاء)، سوء التغذیة، إدمان الكحول المزمن، وفي حال تلقي الجرعات<br />&nbsp;&nbsp; الیومیة القصوى من الباراسیتامول.</p><p dir="RTL">●&nbsp; الباربيتورات (نوع من المهدئات).<br />●&nbsp; كلورامفينيكول (دواء يستخدم لعلاج الالتهابات البكتيرية).<br />●&nbsp; بروبينسيد (دواء يستخدم لعلاج داء النقرس، وأحياناً يستخدم لزيادة مستويات المضاد الحيوي بنسلين في الدم).</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية </strong></p><p>من<strong> </strong>الممكن<strong> </strong>استعمال<strong> </strong>تحاميل<strong> أدول 500 </strong>ملغم<strong> </strong>أثناء<strong> </strong>فترة<strong> </strong>الحمل،<strong> </strong><u>في<strong> </strong>حال<strong> </strong>لزم<strong> </strong>ذلك<strong>.</strong></u><strong> </strong>يجب<strong> </strong>استعمال<strong> </strong>أقل<strong> </strong>جرعة<strong> </strong>ممكنة<strong> </strong>لتقليل<strong> </strong>الألم<strong> </strong>و<strong>/</strong>أو<strong> </strong>الحمى<strong> </strong>لأقصر<strong> </strong>فترة<strong> </strong>ممكنة. يرجى<strong> </strong>منك<strong> </strong>التواصل<strong> </strong>مع<strong> </strong>طبيبك<strong> </strong>المعالج<strong> </strong>في<strong> </strong>حال<strong> </strong>عدم<strong> </strong>تقليل<strong> </strong>الألم<strong> </strong>و<strong>/</strong>أو<strong> </strong>الحمى<strong> </strong>أو<strong> </strong>إذا<strong> </strong>كنت<strong> </strong>بحاجة<strong> </strong>إلى<strong> </strong>استعمال<strong> </strong>هذا<strong> </strong>الدواء<strong> </strong>بصورة<strong> </strong>أكثر<strong> </strong>تكراراً<strong>. </strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتم<strong> </strong>استعمال<strong> </strong>هذا<strong> </strong>الدواء<strong> </strong>عن<strong> </strong>طريق<strong> </strong>المستقيم<strong> </strong>فقط.<strong> </strong>يجب<strong> </strong>عليك<strong> </strong>استعمال<strong> </strong>هذا<strong> </strong>الدواء<strong> </strong>دائماً<strong> </strong>بدقة<strong> </strong>كما<strong> </strong>هو<strong> </strong>مذكور<strong> </strong>في<strong> </strong>هذه<strong> </strong>النشرة<strong> </strong>أو<strong> </strong>وفقاً<strong> </strong>لإرشادات<strong> </strong>طبيبك<strong> </strong>المعالج<strong> </strong>أو<strong> </strong>الصيدلي<strong> </strong>الذي<strong> </strong>تتعامل<strong> </strong>معه<strong>. </strong>يرجى<strong> </strong>منك<strong> </strong>استشارة<strong> </strong>طبيبك<strong> </strong>المعالج<strong> </strong>أو<strong> </strong>الصيدلي<strong> </strong>الذي<strong> </strong>تتعامل<strong> </strong>معه<strong> </strong>مالم<strong> </strong>تكن<strong> </strong>متأكداً<strong> </strong>من<strong> </strong>كيفية<strong> </strong>استعمال<strong> </strong>هذا<strong> </strong>الدواء<strong>. </strong></p><p dir="RTL"><strong>مقدار الجرعة الموصى بها:</strong></p><p dir="RTL"><strong><img src="data:image/jpeg;base64,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" alt="" width="552" height="252" vspace="0" hspace="0" border="0" style="width:552px;height:252px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب<strong> </strong>عدم<strong> </strong>تجاوز<strong> </strong>مقدار<strong> </strong>الجرعة<strong> </strong>المذكورة<strong> </strong>أعلاه<strong>. </strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج، في حال عدم الشعور بالتحسن أو في حال تفاقم حالتك الصحية بعد مرور 3 أيام من استعمال هذا الدواء.</p><p dir="RTL"><strong>كيفية استعمال تحاميل أدول</strong></p><p dir="RTL">●<strong> </strong>عند<strong> </strong>استعمال<strong> </strong>هذه<strong> </strong>التحاميل،<strong> </strong>فإنه<strong> </strong>يلزم<strong> </strong>أن<strong> </strong>يكون<strong> </strong>الجوف<strong> </strong>فارغاً،<strong> </strong>لذا<strong> </strong>في<strong> </strong>حال<strong> </strong>الرغبة<strong> </strong>للذهاب<strong> </strong>إلى<strong> </strong>المرحاض،<strong> </strong>يجب<strong> </strong>التأكد<strong> </strong>من<strong> </strong>القيام<strong> </strong><br /><strong>&nbsp;&nbsp;&nbsp; </strong>بفعل<strong> </strong>ذلك<strong> </strong>قبل<strong> </strong>استعمال<strong> </strong>التحميلة<strong>.</strong></p><p dir="RTL">●<strong> </strong>ربما<strong> </strong>يكون<strong> </strong>من<strong> </strong>الأسهل<strong> </strong>استعمال<strong> </strong>التحميلة<strong> </strong>في<strong> </strong>وضعية<strong> </strong>الاستلقاء<strong> </strong>على<strong> </strong>البطن<strong> </strong>أو<strong> </strong>الجنب<strong> </strong>في<strong> </strong>السرير.</p><p dir="RTL">●<strong> </strong>اغسل<strong> </strong>يديك<strong> </strong>جيداً<strong>. </strong>ثم<strong> </strong>قم<strong> </strong>بإخراج<strong> </strong>التحميلة<strong> </strong>عن<strong> </strong>طريق<strong> </strong>إزالة<strong> </strong>الغلاف<strong> </strong>الخارجي<strong>. </strong>يجب<strong> </strong>عدم<strong> </strong>كسر<strong> </strong>التحميلة<strong> </strong>قبل<strong> </strong>استعمالها.</p><p dir="RTL">●<strong> </strong>ادفع<strong> </strong>التحميلة<strong> </strong>بلطف<strong> </strong>إلى<strong> </strong>داخل<strong> </strong>فتحة<strong> </strong>الشرج<strong> (</strong>المستقيم<strong>) </strong>بحيث<strong> </strong>تدخل<strong> </strong>أولاً<strong> </strong>الجهة<strong> </strong>ذات<strong> </strong>الطرف<strong> </strong>المدبب.<strong> </strong>لجعل<strong> </strong>ذلك<strong> </strong>أكثر<strong> </strong>سهولة<strong> </strong>قم<strong> </strong>بتدفئة<strong> </strong><br /><strong>&nbsp;&nbsp; </strong>التحميلة<strong> </strong>بين<strong> </strong>يديك<strong> </strong>قبل<strong> </strong>إدخالها<strong>.</strong></p><p dir="RTL">●<strong> </strong>يجب<strong> </strong>المحاولة<strong> </strong>في<strong> </strong>البقاء<strong> </strong>بلا<strong> </strong>حركة<strong> </strong>لمدة<strong> </strong>دقيقة<strong> </strong>واحدة<strong> </strong>أو<strong> </strong>دقيقتين،<strong> </strong>بعد<strong> </strong>ذلك<strong> </strong>قم<strong> </strong>بغسل<strong> </strong>اليدين<strong>.</strong></p><p dir="RTL">●<strong> </strong>في<strong> </strong>حال<strong> </strong>استدعى<strong> </strong>الأمر<strong> </strong>استعمال<strong> </strong>تحميلة<strong> </strong>أخرى،<strong> </strong>فيجب<strong> </strong>عليك<strong> </strong>اتباع<strong> </strong>الخطوات<strong> </strong>المذكورة<strong> </strong>أعلاه<strong> </strong>مرة<strong> </strong>أخرى<strong>.</strong></p><p dir="RTL"><strong>إذا قمت باستعمال على سبيل الخطأ تحاميل أدول بجرعة أكثر مما يجب</strong></p><p dir="RTL">يرجى<strong> </strong>منك<strong> </strong>التحدث<strong> </strong>إلى<strong> </strong>طبيبك<strong> </strong>المعالج<strong> </strong>على<strong> </strong>الفور<strong> </strong>في<strong> </strong>حال<strong> </strong>استعمال<strong> </strong>هذا<strong> </strong>الدواء<strong> </strong>بجرعة<strong> </strong>أكثر<strong> </strong>مما<strong> </strong>يجب،<strong> </strong>حتى<strong> </strong>وإن<strong> </strong>كنت<strong> </strong>تشعر<strong> </strong>أنك<strong> </strong>على<strong> </strong>ما<strong> </strong>يرام،<strong> </strong>نظراً<strong> </strong>أن<strong> </strong>استعمال<strong> </strong>باراسيتامول<strong> </strong>بكمية<strong> </strong>كبيرة<strong> </strong>قد<strong> </strong>يسبب<strong> </strong>حدوث<strong> </strong>حالات<strong> </strong>تلف<strong> </strong>متأخرة<strong> </strong>وخطيرة<strong> </strong>في<strong> </strong>الكبد<strong>.</strong></p><p dir="RTL"><strong>إذا سهوت عن استعمال تحاميل أدول </strong></p><p dir="RTL">يجب<strong> </strong>عليك<strong> </strong>عدم<strong> </strong>مضاعفة<strong> </strong>مقدار<strong> </strong>الجرعة<strong> </strong>لتعويض<strong> </strong>الجرعة<strong> </strong>التي<strong> </strong>قد<strong> </strong>سهوت<strong> </strong>عنها<strong>.</strong></p><p dir="RTL"><strong>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كان لديك أية أسئلة إضافية حول استعمال هذا الدواء.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما<strong> </strong>هو<strong> </strong>عليه<strong> </strong>الحال<strong> </strong>مع<strong> </strong>جميع<strong> </strong>الأدوية،<strong> </strong>قد<strong> </strong>يسبب<strong> </strong>هذا<strong> </strong>الدواء<strong> </strong>في<strong> </strong>حدوث<strong> </strong>تأثيرات<strong> </strong>جانبية،<strong> </strong>على<strong> </strong>الرغم<strong> </strong>من<strong> </strong>ذلك<strong> </strong>فإنها<strong> </strong>قد<strong> </strong>لا<strong> </strong>تحدث<strong> </strong>لكل<strong> </strong>شخص<strong>.</strong></p><p dir="RTL"><strong>يرجى منك التوقف عن استعمال تحاميل أدول على الفور والتواصل مع طبيبك المعالج في حال ملاحظة أية علامات تشير إلى حدوث التفاعلات التحسسية. </strong></p><p dir="RTL">تتضمن<strong> </strong>علامات<strong> </strong>التفاعلات<strong> </strong>التحسسية<strong> </strong>على<strong> </strong>طفح<strong> </strong>جلدي،<strong> </strong>مشاكل<strong> </strong>في<strong> </strong>البلع<strong> </strong>أو<strong> </strong>التنفس،<strong> </strong>تورم<strong> </strong>الشفتين،<strong> </strong>الوجه،<strong> </strong>الحلق<strong> </strong>أو<strong> </strong>اللسان<strong>.</strong></p><p dir="RTL"><strong>قد تحدث التأثيرات الجانبية التالية أثناء فترة استعمال هذا الدواء. </strong></p><p dir="RTL"><strong>التأثيرات الجانبية الشائعة (</strong>تؤثر<strong> </strong>على<strong> </strong>أكثر<strong> </strong>من<strong> </strong>شخص<strong> </strong>واحد<strong> </strong>من<strong> </strong>كل<strong> 100 </strong>شخص<strong> </strong>قد<strong> </strong>تلقوا<strong> </strong>هذا<strong> </strong>الدواء)<strong> </strong></p><p dir="RTL">●<strong> &nbsp; </strong>احمرار<strong> </strong>أو<strong> </strong>تقرحات<strong> </strong>داخل<strong> </strong>أو<strong> </strong>حول<strong> </strong>فتحة<strong> </strong>الشرج.</p><p dir="RTL"><strong>التأثيرات الجانبية النادرة (</strong>تؤثر<strong> </strong>على<strong> </strong>ما<strong> </strong>يصل<strong> </strong>إلى<strong> </strong>شخص<strong> </strong>واحد<strong> </strong>من<strong> </strong>كل<strong> 1000 </strong>شخص<strong> </strong>قد<strong> </strong>تلقوا<strong> </strong>هذا الدواء)</p><p dir="RTL">●<strong> </strong>اضطرابات<strong> </strong>في<strong> </strong>الدم.<strong> </strong>في<strong> </strong>حال<strong> </strong>حدوث<strong> </strong>ذلك،<strong> </strong>فقد<strong> </strong>تتعرض<strong> </strong>للكدمات<strong> </strong>أو<strong> </strong>النزيف<strong> </strong>بصور<strong> </strong>أسهل<strong> </strong>من<strong> </strong>المعتاد،<strong> </strong>أو<strong> </strong>احتمالية<strong> </strong>الإصابة<strong> </strong>بالعدوى<strong> </strong><br /><strong>&nbsp;&nbsp;&nbsp; </strong>بصورة<strong> </strong>أكبر،<strong> </strong>أو<strong> </strong>حدوث<strong> </strong>ارتفاع<strong> </strong>في<strong> </strong>درجة<strong> </strong>الحرارة<strong> (</strong>الحمى<strong>) </strong>وتقرحات<strong> </strong>في<strong> </strong>الفم<strong> </strong>أو<strong> </strong>الحلق<strong>.</strong></p><p dir="RTL">●<strong> </strong>اضطرابات<strong> </strong>في<strong> </strong>الكبد. قد<strong> </strong>تتضمن<strong> </strong>الأعراض<strong> </strong>على<strong> </strong>يرقان<strong> (</strong>اصفرار<strong> </strong>لون<strong> </strong>الجلد<strong> </strong>أو العينين).</p><p dir="RTL">يرجى منك التحدث الى طبيبك المعالج أو الصيدلي الذي تتعامل معه في حال حدوث أياً من التأثيرات الجانبية المذكورة أعلاه أو أياً من التأثيرات الجانبية التي لم يتم ذكرها في هذه النشرة</p><p dir="RTL"><strong><u>الإبلاغ عن التأثیرات الجانبیة</u></strong></p><p dir="RTL">یرجى منك إخبار طبیبك المعالج أو الصیدلي الذي تتعامل معه، في حال حدوث أیاً من التأثیرات الجانبیة بما في ذلك أیة تأثیرات جانبیة یحتمل حدوثھا ولم یتم ذكرھا في ھذه النشرة. كما یمكنك أیضاً الإبلاغ عن التأثیرات الجانبیة مباشرة عن طریق:</p><p dir="RTL"><strong>&bull; الإمارات العربية المتحدة: </strong></p><p dir="RTL"><strong>&nbsp;&nbsp; قسم اليقظة الدوائية و الوسائل الطبية</strong></p><p dir="RTL"><strong>&nbsp;&nbsp; إدارة الدواء &ndash; وزارة الصحة&nbsp; الإمارات العربية المتحدة</strong></p><p dir="RTL"><strong>&nbsp;&nbsp; الخط الساخن: </strong>80011111</p><p dir="RTL"><strong>&nbsp;&nbsp; ايميل:</strong> pv@mohap.gov.ae</p><p dir="RTL"><strong>&nbsp;&nbsp; صندوق بريد :</strong> 1853 دبي الإمارات العربية المتحدة.</p><p dir="RTL"><strong>&bull; عمان: </strong></p><p dir="RTL"><strong>&nbsp;&nbsp; دائرة التيقظ والمعلومات الدوائية</strong></p><p dir="RTL"><strong>&nbsp;&nbsp; المديرية العامة للصيدلة والرقابة الدوائية</strong></p><p dir="RTL"><strong>&nbsp;&nbsp; وزارة الصحة، سلطنة عمان</strong></p><p dir="RTL"><strong>&nbsp;&nbsp; هاتف: </strong>0096822357687 / 0096822357686</p><p dir="RTL"><strong>&nbsp;&nbsp; فاكس: </strong>0096822358489</p><p dir="RTL"><strong>&nbsp;&nbsp; البريد الإلكتروني:</strong> dg-padc@moh.gov.om</p><p dir="RTL"><strong>&nbsp;&nbsp; الموقع الإلكتروني: </strong>www.moh.gov.om</p><p dir="RTL"><strong>&bull; المملكة العربیة السعودیة:</strong></p><p dir="RTL"><strong>&nbsp;&nbsp; المركز الوطني للتیقظ الدوائي:</strong></p><p dir="RTL"><strong>&nbsp;&nbsp; - مركز الاتصال الموحد: </strong>۱۹۹۹۹</p><p dir="RTL"><strong>&nbsp;&nbsp; - البرید الإلكتروني: </strong>npc.drug@sfda.gov.sa</p><p dir="RTL"><strong>&nbsp;&nbsp; - الموقع الإلكتروني:</strong> https://ade.sfda.gov.sa</p><p dir="RTL"><strong>&bull; دول الخلیج العربي الأخرى:</strong></p><p dir="RTL"><strong>&nbsp;&nbsp; -</strong> الرجاء الاتصال بالجھات الوطنیة في كل دولة.</p><p dir="RTL">إن تسجیل التأثیرات الجانبیة یساعد في توفیر مزید من المعلومات حول سلامة ھذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;- يحفظ هذا الدواء بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">&ndash; يحفظ في درجة حرارة أقل من &ordm;30م، في العبوة الأصلية، بعيداً عن الحرارة.</p><p dir="RTL">&ndash; يجب عدم استعمال تحاميل أدول بعد تاريخ انتهاء الصلاحية المذكور على العبوة. يشير تاريخ الانتهاء إلى آخر يوم من الشهر<br />&nbsp;&nbsp; المذكور.</p><p dir="RTL">&ndash; يجب عدم استعمال تحاميل أدول إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">&ndash; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن<br />&nbsp;&nbsp; كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة<strong> </strong>الفعالة<strong> </strong>هي<strong> </strong>باراسيتامول<strong>. </strong></p><p dir="RTL">تحتوي<strong> </strong>كل<strong> </strong>تحميلة<strong> </strong>على<strong> </strong>125 ملغم، 250 ملغم أو 500 ملغم<strong> </strong>من<strong> </strong>باراسيتامول<strong>.</strong></p><p dir="RTL">المواد<strong> </strong>الأخرى<strong>: </strong>جليسيريدات<strong> </strong>شبه<strong> </strong>مخلقة<strong> </strong>من<strong> </strong>الأحماض<strong> </strong>الدهنية<strong> </strong>المشبعة<strong> </strong>من<strong> </strong>ذرة<strong> </strong>كربون<strong> 8 </strong>وذرة<strong> </strong>كربون<strong> 18</strong>[سبوكاير أي إم].</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تتوفر<strong> </strong>تحاميل<strong> أدول </strong>125 ملغم، 250ملغم و500 ملغم<strong> </strong>في<strong> </strong>عبوات<strong> </strong>تحتوي<strong> </strong>كلاً<strong> </strong>منها<strong> </strong>على<strong> 10 </strong>تحاميل<strong> </strong>وتحتوي<strong> </strong>العبوات<strong> </strong>المخصصة<strong> </strong>للمستشفيات<strong> </strong>على<strong> 100 </strong>تحميلة<strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الخليج للصناعات الدوائية &quot;جلفار&quot;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            2024/03/22م
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Adol 125mg suppositories 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each suppository contains:
Item no.	Material Name	Scale (mg/Suppository)
		
	Active Ingredients:	
1.		Paracetamol	125.00
		
	Inactive Ingredients	
1.		Semi- synthetic Glycerides of  saturated
fatty acids from C8 to C18 (Suppocire AM)  	795.00

For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Suppositories
Description: Smooth, white to off-white, torpedo shaped suppository.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For the treatment of mild to moderate pain and fever.</p><p><strong>Adol</strong> suppositories may be especially useful in patients unable to take oral forms of paracetamol, e.g. post-operatively or with nausea and vomiting.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Method of administration: </strong>Rectal</p><p><strong><u>Posology</u></strong></p><p><strong>1 year &ndash; 5 years:</strong> 1-2 suppositories every 4 to 6 hours</p><p>Dosages should be based on the child&#39;s age and weight i.e.</p><p>&sect; 1 year (10kg) &ndash; 125mg (1 suppository)</p><p>&sect; 5&nbsp;years (20kg) &ndash; 250mg (2 suppositories)</p><p>These doses may be repeated up to a maximum of 4 times in 24 hours. The dose should not be repeated more frequently than every 4 hours. The recommended dose should not be exceeded. Higher doses do not produce any increase in analgesic effect. The product should not be used for more than 3 days, except on the advice of a doctor<strong>.&nbsp;</strong>Only whole suppositories should be administered &ndash; do not break the suppository before administration</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to either paracetamol or any of the other ingredients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Paracetamol Suppositories should not be combined with other analgesic medications that contain paracetamol. Paracetamol should be given with care to patients with impaired kidney or liver function.</p><p>In general, the habitual use of painkillers, especially with combinations of more than one pain killing active ingredient, can lead to permanent kidney damage with the risk of liver failure (analgesic nephropathy).</p><p>Label and leaflet will state the following warnings:</p><p><u>Label</u>:</p><p>&ldquo;Immediate medical advice should be sought in the event of an overdose, even if the child seems well&rdquo;.</p><p>&ldquo;Do not give with any other Paracetamol-containing products.&rdquo;</p><p><u>Leaflet:</u></p><p>&ldquo;Immediate medical advice should be sought in the event of an overdose, even if the child seems well, because of the risk of delayed, serious liver damage.&rdquo;</p><p>&nbsp;</p><p>Caution is advised if paracetamol is administered concomitantly with flucloxacillin due to increased risk of high anion gap metabolic acidosis (HAGMA), particularly in patients with severe renal impairment, sepsis, malnutrition and other sources of glutathione deficiency (e.g. chronic alcoholism), as well as those using maximum daily doses of paracetamol. Close monitoring, including measurement of urinary 5- oxoproline, is recommended.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The absorption of paracetamol is speeded by metaclopramide or domperidone, and absorption is reduced by colestyramine.</p><p>The anticoagulant effect of warfarin and other coumarins may be increased by long term regular daily use of paracetamol, with increased risk of bleeding. Occasional doses of paracetamol do not have a significant effect on these anticoagulants.</p><p>Enzyme-inducing medicines, such as some antiepileptic drugs (phenytoin, phenobarbital, carbamazepine) have been shown in pharmacokinetic studies to reduce the plasma AUC of paracetamol to approx. 60 %. Other substances with enzyme- inducing properties, e.g. rifampicin are also suspected of causing lowered concentrations of paracetamol. In addition, the risk of liver damage during treatment with maximum recommended doses of paracetamol will be higher in patients being treated with enzyme-inducing agents.</p><p>Phenytoin may reduce the analgesic and antipyretic effects of paracetamol and may increase the formation of the toxic N-acetyl-p-benzoquinone imine (NAPQI) metabolite of paracetamol leading to increased risk of hepatotoxicity.</p><p>Caution should be taken when paracetamol is used concomitantly with flucloxacillin as concurrent intake has been associated with high anion gap metabolic acidosis, especially in patients with risk factors (see section 4.4).</p><p>Drugs which induce hepatic microsomal enzymes such as alcohol, barbiturates and other anticonvulsants, may increase the hepatotoxicity of paracetamol, particularly after overdosage.</p><p>Probenicid inhibits the glucuronidation of paracetamol which can affect the clearance of paracetamol. This should be considered when these medicines are administered concomitantly.&nbsp;</p><p>Paracetamol may affect the pharmacokinetics of chloramphenicol. This interaction should be considered when these medications are administered concomitantly, especially in malnourished patients.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Epidemiological studies in human pregnancy have shown no ill effects due to paracetamol used in the recommended dosage, but patients should follow the advice of their doctor regarding its use.</p><p>Paracetamol is excreted in breast milk but not in clinically significant amounts.</p><p>Available published data do not contraindicate breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="0" cellpadding="0" style="width:528px"><tbody><tr><td style="vertical-align:top"><p>Common</p><p>&gt;1/100</p></td><td style="vertical-align:top"><p><em>Miscellaneous:</em></p></td><td style="vertical-align:top"><p>Redness of the rectal mucous membranes</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p>Rare</p><p>&lt;1/1000</p></td><td style="vertical-align:top"><p><em>General:</em></p></td><td style="vertical-align:top"><p>Allergic reactions including skin rashes</p></td></tr><tr><td style="vertical-align:top"><p><em>Skin:</em></p></td><td style="vertical-align:top"><p>Exanthema, urticaria</p></td></tr><tr><td style="vertical-align:top"><p><em>Liver:</em></p></td><td style="vertical-align:top"><p>Liver damage</p></td></tr><tr><td style="vertical-align:top"><p><em>Genitourinary:</em></p></td><td style="vertical-align:top"><p>Increase in creatinine (mostly secondary to hepatorenal syndrome)</p></td></tr></tbody></table><p>There have been some reports of blood dyscrasias including thrombocytopenia and argranulocytosis, with the use of paracetamol- containing products, but the causal relationship has not been established.</p><p><strong><u>To report any side effect(s):</u></strong></p><p>&sect; <strong>Saudi Arabia:</strong></p><p>The National Pharmacovigilance Centre (NPC):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Centre: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p>&sect; <strong>Other GCC States: </strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Liver damage is possible in adults who have taken 10g or more of paracetamol. Ingestion of 5g or more of paracetamol may lead to liver damage if the patient has risk factors (see below).</p><p>It is considered that excess quantities of a toxic metabolite (usually adequately detoxified by glutathione when normal doses of paracetamol are ingested) become irreversibly bound to liver tissue.</p><p><strong>Risk factors</strong></p><p>If the patient</p><p>a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; is on long term treatment with carbamazepine, phenobarbitone, phenytoin, primidone, rifampicin, St John&#39;s wort or other drugs that induce liver enzymes,</p><p>Or</p><p>b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; regularly consumes ethanol in excess of recommended amounts</p><p>Or</p><p>c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; is likely to be glutathione depleted e.g. eating disorders, cystic fibrosis, HIV infection, starvation, cachexia.</p><p><strong><u>Symptoms</u></strong></p><p>Symptoms of paracetamol overdosage in the first 24 hours are pallor, nausea, vomiting, anorexia and abdominal pain. Liver damage may become apparent 12 to 48 hours after ingestion. Abnormalities of glucose metabolism and metabolic acidosis may occur. In severe poisoning, hepatic failure may progress to encephalopathy, haemorrhage, hypoglycaemia, cerebral oedema, and death. Acute renal failure with acute tubular necrosis, strongly suggested by loin pain, haematuria and proteinuria, may develop in the absence of severe liver damage. Cardiac arrythmias and pancreatitis have been reported.</p><p><strong><u>Management</u></strong><strong>:</strong></p><p>Immediate treatment is essential in the management of paracetamol overdose. Despite a lack of significant early symptoms, patients should be referred to hospital urgently for&nbsp;immediate medical attention. Symptoms may be limited to nausea or vomiting and may not reflect the severity of overdose or the risk of organ damage. Management should be in accordance with established treatment guidelines, see BNF overdose section.</p><p>Treatment with activated charcoal should be considered if the overdose has been taken by mouth within 1 hour. Plasma paracetamol concentration should be measured at 4 hours or later after ingestion (earlier concentrations are unreliable). Treatment with N-acetylcysteine may be used up to 24 hours after ingestion of paracetamol, however, the maximum protective effect is obtained up to 8 hours post-ingestion. The effectiveness of the antidote declines sharply after this time. If required the patient should be given intravenous N-acetylcysteine, in line with the established dosage schedule. If vomiting is not a problem, oral methionine may be a suitable alternative for remote areas, outside hospital.</p><p>Management of patients who present with serious hepatic dysfunction beyond 24h from ingestion should be discussed with NPIS or a liver unit.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> Anilides</p><p><strong>ATC code:</strong> N02BE01</p><p>Paracetamol is an aniline derivative with analgesic and antipyretic actions similar to those of aspirin but with no demonstrable anti-inflammatory activity. &nbsp;It does not affect thrombocyte aggregation or bleeding time.</p><p>Paracetamol is generally well tolerated by patients hypersensitive to acetylsalicylic acid. It produces analgesia by elevation of the pain threshold and antipyresis through action on the hypothalamic heat-regulation centre.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Paracetamol is well absorbed by both oral and rectal routes. Peak plasma concentrations occur about 2 to 3 hours after rectal administration. The plasma half-life is about 2 &frac14; hours and is prolonged in cirrhosis.</p><p>Paracetamol is primarily metabolised in the liver by conjugation to glucuronide and sulphate. A small amount (about 3-10% of a therapeutic dose) is metabolised by oxidation and the reactive intermediate metabolite thus formed is bound preferentially to the liver glutathione and excreted as cystein and mercapturic acid conjugates. Excretion occurs via the kidneys. 2- 3% of a therapeutic dose is excreted unchanged; 80-90% as glucuronide and sulphate and a smaller amount as cystein and mercapturic acid derivatives.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Paracetamol crosses the placenta.</p><p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated-dose toxicity, genotoxicity, carcinogenic potential and toxicity to reproduction and development.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Inactive Ingredients:</u></strong></p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Semi-synthetic glycerides of saturated fatty acids from C<sub>8</sub> to C<sub>18 </sub>(Suppocire AM)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None relevant</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months from the date of manufacturing
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C, in the original container, protected from heat.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&sect; <strong>Pack of 10 Suppositories:</strong> 5 Suppositories in a PVC-PE film strip, 2 strips packed in a printed carton along with a leaflet.</p><p>&sect; <strong>Pack of 100 Suppositories: </strong>5 Suppositories in a PVC-PE film strip, 20 strips packed in a printed carton along with a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Peel the wrapper apart to remove the suppository, gently pushes into the rectum pointed end first.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street
Ras Al Khaimah - United Arab Emirates
P.O. Box 997
Tel. No.:   (9717) 2 461 461
Fax No.:   (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                22. March. 2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>